$4.56
-0.130 (-2.77%)
At Close: Jun 03, 2026
LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market
08:00am, Monday, 28'th Apr 2025
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health M
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs
08:00am, Thursday, 17'th Apr 2025
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced expanded acceptance of insurance to Medicare beneficiarie
LifeMD Is Back To Life
10:10am, Tuesday, 08'th Apr 2025
LifeMD's weight management segment is regaining competitiveness due to the end of GLP-1 compound shortages and expanded insurance coverage, including Medicare. The company is seeing significant growth
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
08:00am, Monday, 31'st Mar 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 24th Annual Needha
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
04:05pm, Tuesday, 25'th Mar 2025
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript
08:17pm, Monday, 10'th Mar 2025
LifeMD, Inc. (NASDAQ:LFMD ) Q4 2024 Results Conference Call March 10, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and Chief Executive Officer Marc Benathen - Chief Financial Offic
LifeMD Reports Fourth Quarter 2024 Results
05:30pm, Monday, 10'th Mar 2025
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60% Adjusted EBITDA increased 78% to $9.0 million Telehealth adjusted EBITDA increased 396% to $5.9 milli
Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound
08:45am, Thursday, 06'th Mar 2025
Telehealth firms Teladoc Health and LifeMD said on Thursday they have signed an agreement with Eli Lilly's direct-to-consumer website LillyDirect pharmacy partner, Gifthealth, to offer patients the we
LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound
08:00am, Thursday, 06'th Mar 2025
NEW YORK, March 06, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced it is integrating with LillyDirect pharmacy provider, Gif
LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum
08:00am, Wednesday, 05'th Mar 2025
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the KeyBanc Capital Markets Healthca
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10
08:05am, Tuesday, 25'th Feb 2025
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 month
LifeMD® Announces Entry Into the Behavioral Health Market
08:05am, Monday, 24'th Feb 2025
Expansion to Include Teletherapy, Psychiatry and Medication Management Behavioral Health Offering to be Led by Industry Veteran Julian Cohen NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (N
LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
08:00am, Tuesday, 28'th Jan 2025
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12th Annual BTIG MedTech, Digital
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
08:00am, Tuesday, 24'th Dec 2024
NEW YORK, Dec. 24, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend
LifeMD initiated with a Neutral at Mizuho
04:33pm, Tuesday, 03'rd Dec 2024
Mizuho initiated coverage of LifeMD with a Neutral rating and $7 price target. The firm notes that the company has succeeded due to the successful uptake of its virtual 'GLP-1 Weight Management' progr
Sign In
Buy LFMD